Mirati Therapeutics SG&A Expense (Quarterly) Trends

Mirati Therapeutics Inc (DELISTED) (MRTX:DL)

58.70 0.00 (0.00%) USD | NASDAQ | Jan 23, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2005. Upgrade now.

Date	Value
September 30, 2023	72.00M
June 30, 2023	75.49M
March 31, 2023	73.49M
December 31, 2022	70.82M
September 30, 2022	60.80M
June 30, 2022	54.23M
March 31, 2022	53.95M
December 31, 2021	43.54M
September 30, 2021	35.18M
June 30, 2021	29.61M
March 31, 2021	28.35M
December 31, 2020	25.34M
September 30, 2020	20.25M
June 30, 2020	19.78M
March 31, 2020	18.05M
December 31, 2019	12.23M
September 30, 2019	10.68M
June 30, 2019	9.894M
March 31, 2019	9.762M
December 31, 2018	6.373M
September 30, 2018	5.313M
June 30, 2018	4.841M
March 31, 2018	5.154M
December 31, 2017	2.984M
September 30, 2017	3.119M

Date	Value
June 30, 2017	3.654M
March 31, 2017	3.693M
December 31, 2016	3.901M
September 30, 2016	3.475M
June 30, 2016	3.786M
March 31, 2016	4.13M
December 31, 2015	3.575M
September 30, 2015	4.161M
June 30, 2015	4.24M
March 31, 2015	3.779M
December 31, 2014	3.366M
September 30, 2014	3.662M
June 30, 2014	2.986M
March 31, 2014	2.685M
December 31, 2013	2.541M
September 30, 2013	3.717M
June 30, 2013	2.382M
March 31, 2013	2.524M
December 31, 2012	1.398M
September 30, 2012	1.717M
June 30, 2012	1.082M
March 31, 2012	1.22M
December 31, 2011	1.225M
September 30, 2011	1.065M
June 30, 2011	1.098M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

9.894M

Minimum

Jun 2019

75.49M

Maximum

Jun 2023

39.65M

Average

32.40M

Median

SG&A Expense (Quarterly) Benchmarks